First Eagle Investment Management
EGRX

First Eagle Investment Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

First Eagle Investment Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-213,822
Closed -$14.8M – 180
2018
Q3 		$14.8M Sell
213,822
-12,511
-6% -$948K 0.04% 120
2018
Q2 		$17.1M Sell
226,333
-274,589
-55% -$17.3M 0.04% 117
2018
Q1 		$26.4M Sell
500,922
-100,583
-17% -$5.85M 0.07% 106
2017
Q4 		$32.1M Hold
601,505
– – 0.08% 111
2017
Q3 		$35.9M Sell
601,505
-50,000
-8% -$3.02M 0.08% 128
2017
Q2 		$51.4M Sell
651,505
-9,500
-1% -$777K 0.12% 105
2017
Q1 		$54.8M Buy
661,005
+26,200
+4% +$1.95M 0.14% 99
2016
Q4 		$50.4M Buy
634,805
+66,600
+12% +$4.84M 0.13% 111
2016
Q3 		$39.8M Buy
+568,205
New +$31.5M 0.1% 128

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.13B AUM 47.25% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return